Plasmin cleaves the juxtamembrane domain and releases truncated species of the urokinase receptor (CD87) from human bronchial epithelial cells

被引:18
作者
Beaufort, N
Leduc, D
Rousselle, JC
Namane, A
Chignard, M
Pidard, D
机构
[1] Inst Pasteur, INSERM, Unite Def Innee & Inflammat, E336,Dept Med Mol, F-75724 Paris 15, France
[2] Inst Pasteur, Dept Biol Struct & Chim, Plate Forme Prote, F-75724 Paris 15, France
关键词
urokinase-type plasminogen activator receptor; plasmin; proteolysis; human bronchial epithelial cell;
D O I
10.1016/j.febslet.2004.08.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The three-domain (D1D2D3) urokinase receptor (CD87) is highly susceptible to cleavage within the D1-D2 linker sequence, but also within the juxtamembrane region by yet poorly characterized proteinases, allowing the release of D1 and D2D3 species in various (patho)physiological body fluids. Using immunoblot analysis and ELISA applied to a recombinant soluble CD87 and to CD87-expressing epithelial cells, we establish that exogenous or in situ generated plasmin proteolyzes CD87 in the D1-D2 linker and D3 carboxyterminal sequences, producing a major soluble D2D3 species. Mass spectrometry analysis of the fragmentation of CD87-related synthetic peptides, and aminoterminal sequencing of D2D3 reveal Arg(83), Arg(89), and Arg(281) as residues targeted by plasmin within human CD87. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 37 条
[31]   Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo [J].
Sidenius, N ;
Sier, CFM ;
Blasi, F .
FEBS LETTERS, 2000, 475 (01) :52-56
[32]   Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice [J].
Sier, CFM ;
Nicoletti, I ;
Santovito, ML ;
Frandsen, T ;
Aletti, G ;
Ferrari, A ;
Lissoni, A ;
Giavazzi, R ;
Blasi, F ;
Sidenius, N .
THROMBOSIS AND HAEMOSTASIS, 2004, 91 (02) :403-411
[33]   A CLEAVED FORM OF THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN INVASIVE TRANSPLANTED HUMAN AND MURINE TUMORS [J].
SOLBERG, H ;
ROMER, J ;
BRUNNER, N ;
HOLM, A ;
SIDENIUS, N ;
DANO, K ;
HOYERHANSEN, G .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (06) :877-881
[34]   Regulation of the immune response by the interaction of chemokines and proteases [J].
Struyf, Sofie ;
Proost, Paul ;
Van Damme, Jo .
ADVANCES IN IMMUNOLOGY, VOL 81, 2003, 81 :1-44
[35]  
Wilhelm OG, 1999, J CELL PHYSIOL, V180, P225, DOI 10.1002/(SICI)1097-4652(199908)180:2<225::AID-JCP10>3.0.CO
[36]  
2-2
[37]   The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality [J].
Wittenhagen, P ;
Kronborg, G ;
Weis, N ;
Nielsen, H ;
Obel, N ;
Pedersen, SS ;
Eugen-Olsen, J .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (05) :409-415